lobbying_activities: 1704472
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1704472 | b2ee136f-4199-4624-9926-dc2dc131d5c3 | Q2 | GSK (FKA GLAXOSMITHKLINE INC.) | 16293 | GSK (FKA GLAXOSMITHKLINE INC.) | 2015 | second_quarter | TAR | YTARNo bill # assigned"provisions related to the emporary duty suspension for preparations, such as tablets or chewing gum, intended to assist smokers to stop smoking (provided for in subheading 2106.90.99) "William, Steve, GarySenate | Commerce, Dept of (DOC),HOUSE OF REPRESENTATIVES,SENATE,State, Dept of (DOS),U.S. Trade Representative (USTR),White House Office | 1123000 | 0 | 0 | 2015-07-17T15:42:38.677000-04:00 |